Anti-VEGF for macular oedema secondary to central retinal vein occlusion
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti-VEGF for Macular Oedema Secondary to Central Retinal Vein Occlusion." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458242/all/Anti_VEGF_for_macular_oedema_secondary_to_central_retinal_vein_occlusion.
Anti-VEGF for macular oedema secondary to central retinal vein occlusion. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/458242/all/Anti_VEGF_for_macular_oedema_secondary_to_central_retinal_vein_occlusion. Accessed February 16, 2025.
Anti-VEGF for macular oedema secondary to central retinal vein occlusion. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458242/all/Anti_VEGF_for_macular_oedema_secondary_to_central_retinal_vein_occlusion
Anti-VEGF for Macular Oedema Secondary to Central Retinal Vein Occlusion [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2025 February 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458242/all/Anti_VEGF_for_macular_oedema_secondary_to_central_retinal_vein_occlusion.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti-VEGF for macular oedema secondary to central retinal vein occlusion
ID - 458242
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458242/all/Anti_VEGF_for_macular_oedema_secondary_to_central_retinal_vein_occlusion
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -